SCHEMBL7932473

SCHEMBL7932473

CNCc1cccnc1NC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.44
NPC1 O15118 6/20 0.44
HTT P42858 2/20 0.44
ATM Q13315 1/20 0.44
MME P08473 1/20 0.43
CYP2C9 P11712 2/20 0.40
NAMPT P43490 1/20 0.40
KDM4E B2RXH2 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
CYP1A2 P05177 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 3/20 0.39
MAPK1 P28482 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3364009 0.86 MME (0.52) RAB9ANPC1HTTATMMME
SCHEMBL28018732 0.82 GRM5 (0.52) RAB9ANPC1HTTATMMME
SCHEMBL4344801 0.81 NPC1 (0.44) RAB9ANPC1HTTATMMME
SCHEMBL19306197 0.80 RAB9A (0.43) RAB9ANPC1HTTATMMME
SCHEMBL28018731 0.79 MME (0.47) RAB9ANPC1HTTATMMME
SCHEMBL31509923 0.79 CYP2A6 (0.41) RAB9ANPC1KDM4EL3MBTL1KMT2A
SCHEMBL7937049 0.79 CYP2A6 (0.41) RAB9ANPC1KDM4EL3MBTL1KMT2A
SCHEMBL2558369 0.77 NPC1 (0.41) RAB9ANPC1HTTATMMME
SCHEMBL17817792 0.77 SMN1; SMN2 (0.44) RAB9ANPC1HTTATMMME
SCHEMBL2693858 0.76 SMN1; SMN2 (0.43) RAB9ANPC1HTTATMMME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010030967-A1 4-ARYLOXYQUINOLIN-2(1H)-ONES AS MTOR KINASE AND PI3 KINASE INHIBITORS, FOR USE AS ANTI-CANCER AGENTS WYETH LLC (US) 2010-03-18 WO disclosed